Our CEO Stéphane Bancel was in Oxfordshire today to see the remarkable progress being made at the Moderna Innovation and Technology Centre (MITC), our new manufacturing facility and clinical laboratories in the UK. ? Once operational, the MITC will have the capacity to produce up to 250 million vaccine doses per year. Unique to the UK, the MITC features state-of-the-art labs and office spaces designed to support high-priority pre-clinical and clinical-stage assays. ? Stéphane was joined by Darius Hughes, UK General Manager, Nicolas Chornet, UK Site Head, and the dedicated teams who are working hard towards completion by 2025.
Moderna
生物技术研究
Cambridge，Massachusetts 624,145 位关注者
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
关于我们
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1?866?MODERNA (1?866?663?3762).
- 网站
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
Moderna的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Cambridge，Massachusetts
- 类型
- 上市公司
- 创立
- 2010
- 领域
- Biotechnology和mRNA Therapeutics
地点
Moderna员工
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX Leader | Critical Design Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
MBA | PfMP, PgMP, PMP Pharmacovigilance Operations
动态
-
We are honored to be recognized as one of the 2024 Mass Save Climate Leaders! ?? We believe that ensuring the health of our planet is critical to positively impacting human health, and that it is our responsibility to grow our company in a way that minimizes adverse impacts on the environment.
The Sponsors of Mass Save are proud to announce the 2024 Climate Leaders to recognize these organizations for their outstanding efforts toward a clean energy future for Massachusetts. Congratulations to the winners! ?? Acton Boxborough Regional School District ?? Berkshire Family YMCA ?? BioMed Realty ?? Boston College ?? Boston Health Care for the Homeless Program ?? Bristol Community College ?? BXP, Inc. ?? City of Boston ?? City of Melrose ?? Fitchburg Art Museum ?? Hampton Inn by Hilton Cape Cod – West Yarmouth ?? H?ns Kissle ?? Mass General Brigham – Martha's Vineyard Hospital ?? Moderna ?? Munters ?? Roche Bros. Supermarkets ?? Siemens Healthineers ?? Town of Ashland, MA. ?? University of Massachusetts Lowell Learn more: https://lnkd.in/dqMt4DNC Berkshire Gas Company Cape Light Compact Eversource Energy Liberty Energy National Grid Unitil
-
In March 2024, the CDC updated its recommendations for protecting yourself and others from respiratory viruses like COVID-19, flu, and RSV. ? Updates to recommendations were made due to changes in the numbers of hospitalizations and deaths from COVID-19, coupled with the increased availability of tools to combat COVID, flu and RSV. ? Here’s the latest guidance and what you need to know: https://lnkd.in/eGxCpqKc
-
-
We’re excited to celebrate Hispanic Latinx Heritage Month, a time to honor the vibrant history and lasting contributions of Hispanic and Latinx communities, both within Moderna and around the world. UNIDOS, our Employee Resource Group, led the way in organizing activities that promoted cultural awareness, professional growth, and community engagement. Their efforts made this month’s celebration meaningful and helped us all connect more deeply with the rich heritage and contributions of Hispanic and Latinx communities. Read more: https://lnkd.in/gYpFS9g6
-
-
Sam Hernandez, Senior Research Associate in Pathology Sciences, has followed a path that blends cutting-edge science with a deep commitment to community. His work focuses on developing complex in vitro models to explore biological processes at the smallest scales, but beyond the science, Sam is driven by collaboration and making a broader impact. ? Learn more about Sam's changemaker journey at Moderna: https://lnkd.in/eqTj8mVm
-
-
Congratulations to our CEO, Stéphane Bancel, on his formal induction into the National Academy of Engineering Class of 2024! As one of the highest honors in the field, Stéphane was recognized for his distinguished contributions to engineering and the development and manufacturing of pharmaceutical products, including the COVID-19 vaccine. #NAE2024
-
-
We announced today that Abbas Hussain, former Chief Executive Officer of Vifor Pharma, will join Moderna’s Board of Directors, effective October 2, 2024. Learn more: https://lnkd.in/gApv9j3T
-
-
It's October 1st – which means if you had COVID in July or earlier during the summer surge, now is the time to get your updated #COVID19 vaccine! The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #COVID19 vaccine. Protect yourself and your loved ones – find a vaccine near you: https://foryouandthem.com
-
Moderna and Cenra Healthcare announced today that the companies have entered into a joint agreement regarding the co-promotion of Moderna’s mRNA respiratory vaccine portfolio in Taiwan, including Moderna’s COVID-19 vaccine. Under the agreement, Moderna will manufacture and distribute its mRNA respiratory #vaccines. Cenra Healthcare will engage in promotion and execute medical education activities to ensure broad access to Moderna’s #mRNA respiratory portfolio across Taiwan. Learn more: https://lnkd.in/exxzTxfr
-